Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

April 11, 2023

Study Completion Date

April 11, 2023

Conditions
Community-acquired PneumoniaSepsisInflammatory ResponseMortalityBiomarkersSIRS
Interventions
DRUG

Tablets

Oral tablets of similar appearance to active study drug

DRUG

Clarithromycin 500mg

Oral tablets of 500mg of clarithromycin

Trial Locations (18)

12462

4th Department of Internal Medicine, Attikon University Hospital, Athens

Unknown

1st Department of Internal Medicine, Amalia Fleming General Hospital, Athens

1st Department of Internal Medicine, Gennimatas General Hospital, Athens

1st Department of Internal Medicine, Konstantopouleio-Patission General Hospital, Athens

1st Department of Internal Medicine, THRIASIO Eleusis General Hospital, Athens

1st Department of Internal Medicine,Korgialeneio-Benakeio General Hospital, Athens

2nd Department of Internal Medicine, Attikon University Hospital, Athens

2nd Department of Internal Medicine, Thriasio General Hospital, Athens

3rd Department of Internal Medicine, KORGIALENEION-BENAKEION Athens General Hospital, Athens

3rd Department of Internal Medicine, Sotiria General Hospital, Athens

5th Department of Internal Medicine, Evangelismos General Hospital, Athens

Department of Chest Medicine, EVANGELISMOS Athens General Hospital, Athens

Department of Pulmonary Medicine, General Hospital of Kerkyra, Corfu

1st Department of Internal Medicine, Ioannina University General Hospital, Ioannina

Department of Internal Medicine, Larissa University General Hospital, Larissa

Department of Internal Medicine, Patras University General Hospital, Pátrai

2nd Department of Internal Medicine, Tzaneion General Hospital, Piraeus

Department of Emergency Medicine, Tzanneion General Hospital, Piraeus

All Listed Sponsors
lead

Hellenic Institute for the Study of Sepsis

OTHER

NCT04724044 - Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia | Biotech Hunter | Biotech Hunter